PCTAIRE-3 Activators
PCTAIRE-3 Activators encompass a range of chemical compounds that, through various signaling pathways, indirectly enhance the functional activity of PCTAIRE-3. Compounds such as Forskolin and Dibutyryl-cAMP elevate intracellular cAMP, thereby activating PKA, which is known to phosphorylate target proteins, potentially including PCTAIRE-3, thereby enhancing its kinase activity in processes like cell cycle regulation. Similarly, Isoproterenol, a beta-adrenergic agonist, also raises cAMP levels, indirectly promoting PCTAIRE-3 activation. Retinoic Acid modulates cellular differentiation, which could implicate PCTAIRE-3 in the enhanced signaling required for these processes, especially in neuronal cells. Epigallocatechin Gallate (EGCG) and Staurosporine, both kinase inhibitors, could selectively inhibit kinases that normally suppress PCTAIRE-3, allowing for an indirect increase in its activity. Sphingosine-1-phosphate, while primarily involved in signal transduction, could intersect with pathways that engage PCTAIRE-3, enhancing its activity in cellular signaling.
Furthermore, compounds like LY294002, a PI3K inhibitor, and PD98059, an MEK inhibitor, may shift cellular signaling dynamics, leading to an indirect upregulation of PCTAIRE-3 activity. These inhibitors could reduce the activity of competing pathways or release PCTAIRE-3 from negative regulation. A23187 (Calcimycin) increases intracellular calcium, potentially affecting calcium-dependent protein kinases and phosphatases that modulate PCTAIRE-3's role, leading to enhanced activity. IBMX, by inhibiting phosphodiesterases, increases cAMP levels, which may further contribute to PKA-mediated activation of PCTAIRE-3. Lastly, Zoledronic Acid, by interfering with the mevalonate pathway, could alter the function or localization of proteins interacting with PCTAIRE-3, thereby enhancing its kinase activity. Collectively, these activators, through their targeted biochemical mechanisms, facilitate the enhancement of PCTAIRE-3 mediated functions in various cellular contexts.
SEE ALSO...
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly raises intracellular cAMP levels, which in turn activates PKA. PKA can phosphorylate PCTAIRE-3, leading to its activation and enhancing its kinase activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid influences cellular differentiation and proliferation processes that may involve the PCTAIRE-3 kinase in neuronal cells, potentially modulating its activity through changes in the cellular context. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which increases cAMP levels by preventing its degradation. Elevated cAMP activates PKA, which can then enhance the activity of PCTAIRE-3. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4, leading to increased cAMP levels and subsequent activation of PKA. PKA activation may enhance PCTAIRE-3 activity by phosphorylation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, as a kinase inhibitor, could indirectly enhance PCTAIRE-3 activity by inhibiting competitive or regulatory kinases that modulate its function, thus favoring PCTAIRE-3 mediated pathways in cell signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
D-erythro-Sphingosine-1-phosphate is involved in signal transduction pathways that may intersect with PCTAIRE-3's role in cellular processes, thus indirectly enhancing its kinase activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, may shift cellular signaling pathways in a way that indirectly upregulates PCTAIRE-3 activity by altering downstream signaling components that PCTAIRE-3 interacts with. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine, a broad-spectrum kinase inhibitor, might preferentially inhibit kinases that negatively regulate PCTAIRE-3, indirectly enhancing the activity of PCTAIRE-3 in signal transduction. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A stable cAMP analog that activates PKA. Activated PKA is known to phosphorylate and enhance the activity of associated kinases such as PCTAIRE-3. | ||||||
Zardaverine | 101975-10-4 | sc-201208 sc-201208A | 5 mg 25 mg | $88.00 $379.00 | 1 | |
A dual PDE3/4 inhibitor, Zardaverine increases cAMP levels, which can lead to PKA activation. This activation may enhance PCTAIRE-3 activity through phosphorylation. | ||||||